Skin necrosis with minidose warfarin used for prophylaxis against thromboembolic disease after hip surgery.
نویسندگان
چکیده
Warfarin sodium is one of the most commonly prescribed oral anticoagulants, It has been proven to be an effective agent in the prophylaxis of thromboembolic disease and fatal pulmonary embolism in total joint arthroplasty and emergency hip fracture surgery. A rare, undesirable side effect of warfarin is skin necrosis. The authors present a case of skin necrosis after use of warfarin for prophylaxis against thromboembolic disease after surgery. To the authors' knowledge, this is only the second case in the orthopedic literature of this complication when warfarin was used for prophylaxis against thromboembolic disease.
منابع مشابه
Efficacy of fixed minidose warfarin prophylaxis in total hip replacement.
OBJECTIVE To determine whether a small fixed perioperative dose of warfarin would prevent deep vein thrombosis after total hip replacement. DESIGN Prospective, randomised, double blind placebo controlled trial. SETTING Winford Orthopaedic Hospital, Bristol. SUBJECTS 148 patients having primary total hip replacement. INTERVENTION Warfarin 1 mg given daily for one week before and three we...
متن کاملPrevention of venous thromboembolic disease after total hip and knee arthroplasty.
Patients undergoing total hip and knee arthroplasty are at increased risk for the development of venous thromboembolic disease, and there is general agreement that these patients require prophylaxis. The selection of a prophylactic agent involves a balance between efficacy and safety and often needs to be individualized for specific patients and institutions. Despite extensive research, the ide...
متن کاملFixed minidose warfarin: a new approach to prophylaxis against venous thrombosis after major surgery.
A prospective study was carried out to see whether a small fixed dose of warfarin (1 mg daily) given before operation (mean 20 days) would prevent deep vein thrombosis in patients having major gynaecological surgery. One hundred and four patients were randomised into three groups: fixed minidose warfarin; full dose oral anticoagulation; and no treatment (controls). There was a significantly low...
متن کاملPrevention of venous thrombosis with minidose warfarin after joint replacement.
Without prophylaxis 5-10% of patients having elective hip replacement develop clinically important venous thrombosis and about 5% develop symptomatic embolism, which is fatal in up to 0-5%.' Effective preventive methods exist, but many orthopaedic surgeons do not use them systematically because they tend to be complex, cumbersome, dangerous, or not generally available.' Minidose warfarin (a fix...
متن کاملThe John Charnley Award: prevention of readmission for venous thromboembolic disease after total hip arthroplasty.
UNLABELLED Venous thromboembolic disease remains the most common reason for readmission after total hip arthroplasty. Prospective analysis of screening contrast venography was done from 1984 to 2003 in 1972 patients having elective total hip arthroplasty. Patients with deep venous thrombosis or pulmonary embolism received warfarin therapy; those with negative venograms received no further antic...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Orthopedics
دوره 16 6 شماره
صفحات -
تاریخ انتشار 1993